Show Summary Details
Page of

Lorazepam for Generalized Status Epilepticus 

Lorazepam for Generalized Status Epilepticus
Lorazepam for Generalized Status Epilepticus

Pue Farooque

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 12 July 2020

This chapter provides a summary of a landmark study in epilepsy. What is the best initial drug treatment for generalized status epilepticus? Starting with that question, it describes the basics of the study, including funding, study location, who was studied, how many patients, study design, study intervention, follow-up, endpoints, results, and criticism and limitations. Lorazepam was shown to be either equally or more efficacious in the treatment of status epilepticus versus other medications. Given its easier use, the researchers preferred it as the first-line treatment for status epilepticus. The chapter briefly reviews other relevant studies and information, discusses implications, and concludes with a relevant clinical case.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.